Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Medistim ASA (MD1.F)

Compare
13.35
+0.30
+(2.30%)
At close: 9:47:23 PM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Ms. Kari Eian Krogstad CEO & President 286.28k -- 1964
Mr. Thomas Jakobsen Chief Financial Officer 186.32k -- 1969
Mr. Helge Borslid Vice President of Operations 140.53k -- --
Ms. Hæge Johanne Krogh Wetterhus Vice President of Marketing 152.06k -- 1964
Mr. Hakon Grothe Chief Innovation Officer 152.68k -- --
Mr. Ole Arne Eiksund Chief Business Development Officer 146.44k -- 1967
Mr. Roger Reino Morberg Vice President of Sales - APAC 171.36k -- 1964
Ms. Stephanie D'Avout Stenhagen Vice President of Sales EMEA 141.1k -- --
Mr. Mike Karim Chief Commercial Officer -- -- --
Mr. Ole Jorgen Robsrud Managing Director of Medistim Norge AS 146.54k -- --

Medistim ASA

Oekernveien 94
Oslo, 0579
Norway
47 23 05 96 60 https://www.medistim.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
154

Description

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Corporate Governance

Medistim ASA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 9, 2025 at 10:59 AM UTC

Medistim ASA Earnings Date

Recent Events

April 25, 2024 at 12:00 AM UTC

Ex-Dividend Date